SCHEMBL8224964

SCHEMBL8224964

CCOC(=O)[C@@H]1CCN2CC[C@](Cc3ccccc3)(NC(=O)OC(C)(C)C)C(=O)N12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPIA P62937 2/20 0.42
LMNA P02545 1/20 0.37
F2 P00734 2/20 0.36
F10 P00742 1/20 0.36
PRSS1 P07477 1/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
KDM4E B2RXH2 1/20 0.36
ACE P12821 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
FKBP1A P62942 2/20 0.35
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
PKM P14618 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
CTSL P07711 1/20 0.35
KLK5 Q9Y337 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8224962 1.00 PPIA (0.42) PPIALMNAF2F10PRSS1
SCHEMBL8224965 1.00 PPIA (0.42) PPIALMNAF2F10PRSS1
SCHEMBL8418697 0.90 PPIA (0.45) PPIAF2F10PRSS1KMT2A
SCHEMBL8224968 0.90 PPIA (0.45) PPIAF2F10PRSS1KMT2A
SCHEMBL27475666 0.73 PPIA (0.52) PPIAF2F10PRSS1KMT2A
SCHEMBL8227078 0.73 F2 (0.47) PPIAF2F10PRSS1KMT2A
SCHEMBL8225058 0.73 F2 (0.47) PPIAF2F10PRSS1KMT2A
SCHEMBL8219756 0.71 PPIA (0.42) PPIAF2F10PRSS1KMT2A
SCHEMBL8087931 0.71 PPIA (0.51) PPIAF2F10PRSS1KMT2A
SCHEMBL8915173 0.69 PPIA (0.50) PPIAF2F10PRSS1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7511039-B2 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins MYRIAD GENETICS, INC. (US) 2009-03-31 US disclosed
US-20060276408-A1 Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins MYRIAD GENETICS, INCORPORATED (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276408-A1 Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins SERPINB1, SERPINE1, SERPINA2 PPIA 732/4885LMNA 583/4885F2 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.